Vincent Aurentz
Insider CIK 1657494 · ARNA Executive VP and CBO · EPRS Chief Business Officer · IKT Director · LBPH Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IKT Inhibikase Therapeutics, I | A Award deriv | 2026-06-26 | 2026-06-30 | 155,000 | — | $0 | 155,000 | SEC↗ |
| IKT Inhibikase Therapeutics, I | D To issuer | 2026-02-21 | 2026-02-24 | 255,299 | — | $0 | 510,596 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-06-30 | 2025-07-02 | 108,176 | — | $0 | 108,176 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-02-21 | 2025-07-02 | 134,427 | — | $0 | 134,427 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-02-21 | 2025-02-25 | 134,427 | — | $0 | 134,427 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 22,500 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 12,500 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 12,367 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 7,214 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 12,367 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | A Award deriv | 2024-05-23 | 2024-05-24 | 22,500 | — | $0 | 22,500 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | A Award deriv | 2023-05-25 | 2023-05-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | A Award deriv | 2022-05-24 | 2022-05-31 | 12,367 | — | $0 | 12,367 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | D To issuer deriv | 2022-03-11 | 2022-03-11 | 38,850 | — | $0 | 0 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | D To issuer deriv | 2022-03-11 | 2022-03-11 | 75,000 | — | $0 | 0 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | D To issuer deriv | 2022-03-11 | 2022-03-11 | 94,976 | — | $0 | 0 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | D To issuer deriv | 2022-03-11 | 2022-03-11 | 70,000 | — | $0 | 0 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | D To issuer deriv | 2022-03-11 | 2022-03-11 | 15,200 | — | $0 | 0 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | D To issuer deriv | 2022-03-11 | 2022-03-11 | 45,000 | — | $0 | 0 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | D To issuer deriv | 2022-03-11 | 2022-03-11 | 77,000 | — | $0 | 0 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | J Other | 2022-03-11 | 2022-03-11 | 21,462 | — | $0 | 0 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | J Other | 2022-03-11 | 2022-03-11 | 27,842 | — | $0 | 28,122 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | J Other | 2022-03-11 | 2022-03-11 | 6,660 | — | $0 | 21,462 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award | 2022-01-03 | 2022-01-05 | 21,462 | — | $0 | 55,122 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | A Award deriv | 2021-09-14 | 2021-09-14 | 12,367 | — | $0 | 12,367 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | A Award deriv | 2021-09-14 | 2021-09-14 | 7,214 | — | $0 | 7,214 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2021-03-01 | 2021-03-03 | 38,850 | — | $0 | 38,850 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2021-03-01 | 2021-03-03 | 15,200 | — | $0 | 15,200 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award | 2021-03-01 | 2021-03-03 | 6,660 | — | $0 | 33,660 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise deriv | 2021-02-16 | 2021-02-18 | 2,500 | — | $0 | 77,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise deriv | 2021-02-16 | 2021-02-18 | 24 | — | $0 | 94,976 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise | 2021-02-16 | 2021-02-18 | 24 | $35.60 | $854 | 29,524 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | S Sale | 2021-02-16 | 2021-02-18 | 2,524 | $85.00 | $214.5K | 27,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise | 2021-02-16 | 2021-02-18 | 2,500 | $14.60 | $36.5K | 29,500 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise deriv | 2021-01-07 | 2021-01-11 | 18,000 | — | $0 | 0 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise | 2021-01-07 | 2021-01-11 | 18,000 | — | $0 | 27,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise deriv | 2020-11-25 | 2020-11-30 | 9,000 | — | $0 | 18,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise | 2020-11-25 | 2020-11-30 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise deriv | 2020-06-02 | 2020-06-04 | 10,000 | — | $0 | 45,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise deriv | 2020-06-02 | 2020-06-04 | 10,000 | — | $0 | 79,500 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise deriv | 2020-06-02 | 2020-06-04 | 5,000 | — | $0 | 95,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise | 2020-06-02 | 2020-06-04 | 10,000 | $14.60 | $146.0K | 20,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise | 2020-06-02 | 2020-06-04 | 5,000 | $35.60 | $178.0K | 25,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | S Sale | 2020-06-02 | 2020-06-04 | 25,000 | $65.00 | $1.63M | 0 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise | 2020-06-02 | 2020-06-04 | 10,000 | $17.10 | $171.0K | 10,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2020-03-01 | 2020-03-03 | 70,000 | — | $0 | 70,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | S Sale | 2020-02-05 | 2020-02-07 | 9,000 | $50.00 | $450.0K | 0 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise deriv | 2019-10-14 | 2019-10-16 | 9,000 | — | $0 | 27,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise | 2019-10-14 | 2019-10-16 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise deriv | 2019-09-09 | 2019-09-10 | 25,000 | — | $0 | 55,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise deriv | 2019-09-09 | 2019-09-10 | 10,000 | — | $0 | 89,500 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise deriv | 2019-09-09 | 2019-09-10 | 30,000 | — | $0 | 100,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise | 2019-09-09 | 2019-09-10 | 30,000 | $35.60 | $1.07M | 65,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise | 2019-09-09 | 2019-09-10 | 25,000 | $17.10 | $427.5K | 25,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise | 2019-09-09 | 2019-09-10 | 10,000 | $14.60 | $146.0K | 35,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | S Sale | 2019-09-09 | 2019-09-10 | 44,672 | $50.48 | $2.26M | 20,328 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | S Sale | 2019-09-09 | 2019-09-10 | 20,328 | $51.23 | $1.04M | 0 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2019-01-04 | 2019-01-08 | 18,000 | — | $0 | 18,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2019-01-04 | 2019-01-08 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2018-01-19 | 2018-01-22 | 130,000 | — | $0 | 130,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2017-02-13 | 2017-02-14 | 995,000 | — | $0 | 995,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2016-08-15 | 2016-08-15 | 800,000 | — | $0 | 800,000 | SEC↗ |
| EPRS EPIRUS Biopharmaceuticals, | A Award deriv | 2016-05-27 | 2016-05-31 | 230,000 | — | $0 | 230,000 | SEC↗ |
| EPRS EPIRUS Biopharmaceuticals, | P Buy | 2015-12-17 | 2015-12-21 | 2,200 | $3.43 | $7.5K | 2,200 | SEC↗ |
| EPRS EPIRUS Biopharmaceuticals, | P Buy | 2015-12-09 | 2015-12-11 | 2,800 | $3.85 | $10.8K | 2,800 | SEC↗ |
| EPRS EPIRUS Biopharmaceuticals, | A Award deriv | 2015-11-09 | 2015-11-10 | 219,487 | — | $0 | 219,487 | SEC↗ |